|
시장보고서
상품코드
1404711
정맥주사액 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 영양소별, 지역별, 부문별 예측(2024-2030년)Intravenous Solutions Market Size, Share & Trends Analysis Report By Product (TPN, PPN), By Nutrients (Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids) By Region (Asia Pacific, North America), And Segment Forecasts, 2024 - 2030 |
||||||
정맥주사액 시장 성장 및 동향:
Grand View Research, Inc.의 최신 보고서에 따르면, 세계 정맥주사액 시장 규모는 2030년까지 220억 달러에 달할 것으로 예상되며, 예측 기간 동안 8%의 CAGR을 기록할 것으로 예상됩니다.
특히 인도, 중국 등 신흥국에서는 조산율이 높아 예측 기간 동안 시장 성장의 원동력이 될 것으로 예상되며, WHO에 따르면 10 명 중 1 명은 조산아로 전 세계가 우려하고 있는 상황입니다. 따라서 신흥국의 높은 조산 발생률, 의료 인프라 개선, 의료비 및 환자 인식 증가는 예측 기간 동안 시장 촉진요인으로 큰 영향을 미칠 것으로 예상됩니다.
비경구 지질 에멀전의 사용은 조산으로 인한 사망률을 낮추기 위해 여러 당국이 광범위하게 초점을 맞추고 있으며, 2021년 현재 미국의 조산율은 약 10.5%에 달합니다. 또한 조산으로 인한 사회적, 경제적 비용은 연간 252억 달러에 달하는 것으로 추정됩니다. 따라서, 출산 후 보조 영양을 필요로 하는 신생아들이 많다는 점은 예측 기간 동안 시장 수요를 증가시킬 것으로 예상됩니다.
또한, 팬데믹 기간 동안 증가된 영양실조 문제로 고통받는 환자들에게 비경구 영양제 사용을 정당화하는 여러 연구도 시장 성장에 기여하고 있습니다. 예를 들어, Journal of the Academy of Nutrition and Dietetics에 게재된 논문에 따르면, COVID-19 치료를 위해 중환자실에 입원한 환자 중 상당수가 급성 영양실조로 고통받고 있습니다. 따라서 팬데믹 기간 동안 시장에서 비경구 영양 제품의 사용량이 증가할 것으로 예상됩니다.
COVID-19 양성 환자에서 특정 미량 영양소와 비타민이 결핍된 경우가 많아 유해한 것으로 보고되고 있습니다. 따라서 이러한 환자들은 권장 식이 섭취량을 충족시키기 위해 정맥주사를 권장하고 있습니다. 의사와 영양 전문가들은 COVID-19 환자에서 경장영양보다 비경구영양을 선호했습니다. 특히 경장영양은 비위관 설치가 필요해 COVID-19 환자에게 제공되는 비침습적 인공호흡을 방해하기 때문에 COVID-19 입원 환자에서 영양 용액 흡인 및 영양 부족의 위험이 높아져 비경구영양 채택이 증가하고 있습니다.
정맥주사액 시장 보고서 하이라이트
- 2023년에는 종합비경구영양(TPN) 분야가 66.3%로 압도적인 시장 점유율을 차지하며 예측 기간 동안 가장 높은 성장률(CAGR 8.2%)을 보일 것으로 예상되며, TPN은 정맥 내(IV) 기술을 통해 종합적인 영양 세트를 투여하는 것을 포함합니다.
- 2023년에는 1회용 아미노산 용액 부문이 시장을 주도하며 31.6%의 큰 점유율을 차지했습니다. 연구에 따르면 단일 용량 아미노산은 완전한 단백질 공급원을 제공하고 다른 비경구 제제와 함께 쉽게 맞춤화 할 수 있으며 투여가 용이합니다.
- Assure Infusions, Inc.가 미국 내 수액 공급과 수요의 격차를 해소하기 위해 미국 플로리다 주 Bartow에 첨단 제조 시설을 건설하기 위해 2,000만 달러를 투자할 것이라고 발표했습니다.
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 정맥주사액 시장 변수와 동향
- 정맥주사액 시장 계통 전망
- 부수 시장 전망
- 시장 역학
- 시장 성장 촉진요인의 영향 분석
- 시장 성장 억제요인 분석
- 규제 체계
- 규격과 준거
- 상환 시나리오
- COVID-19 팬데믹의 영향
- 업계 분석 툴
- Porters 분석
- 거시경제 분석
제4장 정맥주사액 시장 : 제품 분석
- 제품 변동 분석과 시장 점유율, 2023년과 2030년
- 제품별
- 완전 정맥 영양
- 완전 정맥 영양 시장, 2018-2030년
- 말초 정맥 영양
- 말초 정맥 영양 시장, 2018-2030년
제5장 정맥주사액 시장 : 영양소 분석
- 영양소 변동 분석과 시장 점유율, 2023년과 2030년
- 영양소별
- 탄수화물
- 탄수화물 시장, 2018-2030년
- 일회 투여 아미노산 용액
- 일회 투여 아미노산 용액 시장, 2018-2030년
- 비타민과 미네랄
- 비타민과 미네랄, 2018-2030년
- 비경구 지질 에멀전
- 비경구 지질 에멀전, 2018-2030년
- 기타
- 기타 시장, 2018-2030년
제6장 정맥주사액 시장 : 지역 추정·동향 분석
- 정맥주사액 시장 : 지역별 전망
- 북미
- 북미의 정맥주사액 시장 추정과 예측, 2018-2030년
- 미국
- 캐나다
- 유럽
- 유럽의 정맥주사액 시장 추정과 예측, 2018-2030년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양의 정맥주사액 시장 추정과 예측, 2018-2030년
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
- 라틴아메리카
- 라틴아메리카의 정맥주사액 시장 추정과 예측, 2018-2030년
- 멕시코
- 브라질
- 아르헨티나
- 중동 및 아프리카(MEA)
- 중동 및 아프리카의 정맥주사액 시장 추정과 예측, 2018-2030년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
제7장 경쟁 분석
- 기업 분류
- Fresenius Kabi AG
- Pfizer Inc.
- Otsuka Pharmaceutical Co. Ltd.
- Baxter, B. Braun Melsungen AG
- Vifor Pharma Management Ltd.
- JW Life Science
- 참여자 개요
- 재무 실적
- 제품 벤치마크
- 시장 진출 기업 분류
- 히트맵 분석
- 기업의 시장 점유율 분석, 2022년
- 전략 매핑
- 인수합병
- 제품 발매
- 파트너십과 협업
- 제품 승인
- 확대
- 기타
제8장 애널리스트의 견해
ksm 24.01.17Intravenous Solutions Market Growth & Trends:
The global intravenous solutions market size is expected to reach USD 22.0 billion by 2030, registering a CAGR of 8% during the forecast period, according to a new report by Grand View Research, Inc. The high prevalence of preterm births, especially in emerging economies such as India and China, is expected to drive market growth during the forecast period. According to WHO, 1 in 10 babies are born preterm, and this is a global concern. Thus, the high incidence of preterm births in emerging economies, improved healthcare infrastructure, and growing healthcare expenditure & patient awareness are expected to be high impact rendering drivers of the market during the forecast period.
The use of parenteral lipid emulsions is driven by the extensive focus of various authorities to limit preterm birth mortality. As of 2021, the preterm birth rate in the U.S. was about 10.5%. Moreover, the annual societal, and economic cost was estimated at USD 25.2 billion for preterm births. Hence, the presence of many neonates requiring supplementary postbirth nutrition is expected to boost the market demand over the forecast period.
In addition, several studies justify the use of parenteral nutrition for patients suffering from malnutrition problems, which increased during the pandemic, leading to market growth. For instance, according to an article published in the Journal of the Academy of Nutrition and Dietetics, many patients admitted to the ICU for COVID-19 treatment suffer from acute malnourishment. Hence, the usage of parenteral nutrition products is expected to increase in the market during the pandemic.
In COVID-19-positive patients, high deficiency of specific micronutrients and vitamins has been reported to be detrimental. Thus, intravenous administration is recommended in such patients to meet the recommended dietary intake. Physicians and nutrition specialists preferred parenteral nutrition over enteral nutrition in COVID-19 patients since enteral nutrition specifically requires the setup of nasogastric tubes, which hampers the noninvasive ventilation provided to COVID-19 patients. The increased risk of nutritional solution aspiration and underfeeding in hospitalized patients for COVID-19 has led to increased adoption of parenteral nutrition.
Intravenous Solutions Market Report Highlights:
- In 2023, the Total Parenteral Nutrition (TPN) segment held a dominant market share of 66.3% and is projected to experience the highest growth rate (CAGR of 8.2%) during the forecast period. TPN involves administering a comprehensive set of nutrients through an intravenous (IV) technique
- In 2023, the market was led by the single-dose amino acid solution segment, holding a significant share of 31.6%. Studies have shown that single-dose amino acids offer a complete protein source, are easily customizable with other parenteral formulations, and are straightforward to administer
- In 2023, North America held a dominant market share of 41%, credited to key players, favorable regulations, and strong reimbursement in countries like the U.S. Assure Infusions, Inc. announced a USD 20 million investment to build an advanced manufacturing facility in Bartow, Florida, addressing the IV solutions demand-supply gap in the U.S.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.1.1 Segment Definitions
- 1.1.1.1 Product Segment
- 1.1.1.2 Nutrient Segment
- 1.1.1 Segment Definitions
- 1.2 Regional Scope
- 1.3 Estimates And Forecast Timeline
- 1.4 Objectives
- 1.4.1 Objective - 1
- 1.4.2 Objective - 2
- 1.4.3 Objective - 3
- 1.5 Research Methodology
- 1.6 Information Procurement
- 1.6.1 Purchased Database
- 1.6.2 GVR's Internal Database
- 1.6.3 Secondary Sources
- 1.6.4 Primary Research
- 1.7 Information Or Data Analysis
- 1.7.1 Data Analysis Models
- 1.8 Market Formulation & Validation
- 1.9 Model Details
- 1.9.1 Commodity Flow Analysis
- 1.9.1.1 Research Scope And Assumptions
- 1.9.1 Commodity Flow Analysis
- 1.10 List Of Secondary Sources
- 1.11 List Of Primary Sources
- 1.12 List Of Abbreviations
Chapter 2 Executive Summary
- 2.1 Market Snapshot
- 2.2 Segment Snapshot
- 2.3 Competitive Landscape
Chapter 3 Intravenous Solutions Market Variables And Trends
- 3.1 Intravenous Solutions Market Lineage Outlook
- 3.1.1 Ancillary Market Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Impact Analysis
- 3.2.1.1 Growing Number Of Premature Births
- 3.2.1.2 Increasing Incidence Of Cancer
- 3.2.1.3 Increasing Risk Of Malnutrition
- 3.2.1.4 Growing Geriatric Population
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 Shortage Of Parenteral Nutrition Products
- 3.2.2.2 Increased Use Of Enteral Nutrition
- 3.2.2.3 High Risk Of Infections
- 3.2.1 Market Driver Impact Analysis
- 3.3 Regulatory Framework
- 3.3.1 Standards And Compliances
- 3.3.1.1 North America
- 3.3.1.2 Europe
- 3.3.1.3 Apac
- 3.3.1.4 Latin America
- 3.3.1.5 Mea
- 3.3.2 Reimbursement Scenario
- 3.3.2.1 U.S.
- 3.3.2.2 Canada
- 3.3.2.3 Germany
- 3.3.2.4 UK
- 3.3.2.5 Japan
- 3.3.2.6 Australia
- 3.3.2.7 China
- 3.3.1 Standards And Compliances
- 3.4 Impact Of Covid-19 Pandemic
- 3.5 Industry Analysis Tools
- 3.5.1 Porter's Analysis
- 3.5.2 Macroeconomic Analysis
Chapter 4 Intravenous Solutions Market: Product Analysis
- 4.1 Product Movement Analysis & Market Share, 2023 & 2030
- 4.2 Intravenous Solutions Market Estimates & Forecast, By Product (Revenue In USD Million And Volume In Thousand Units)
- 4.3 Total Parenteral Nutrition
- 4.3.1 Total Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 4.4 Peripheral Parenteral Nutrition
- 4.4.1 Peripheral Parenteral Nutrition Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 5 Intravenous Solutions Market: Nutrients Analysis
- 5.1 Nutrients Movement Analysis & Market Share, 2023 & 2030
- 5.2 Intravenous Solutions Market Estimates & Forecast, By Nutrients (Revenue In USD Million And Volume In Thousand Units)
- 5.3 Carbohydrates
- 5.3.1 Carbohydrates Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 5.4 Single-dose Amino Acid Solution
- 5.4.1 Single-dose Amino Acid Solution Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 5.5 Vitamins & Minerals
- 5.5.1 Vitamins & Minerals, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 5.6 Parenteral Lipid Emulsion
- 5.6.1 Parenteral Lipid Emulsion, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 5.7 Others
- 5.7.1 Others Market, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 6 Intravenous Solutions Market: Regional Estimates & Trend Analysis
- 6.1 Intravenous Solutions Market: Regional Outlook
- 6.2 North America
- 6.2.1 North America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.2.2 U.S.
- 6.2.2.1 Key Country Dynamics
- 6.2.2.2 U.S. Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.2.3 Canada
- 6.2.3.1 Key Country Dynamics
- 6.2.3.2 Canada Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3 Europe
- 6.3.1 Europe Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.2 UK
- 6.3.2.1 Key Country Dynamics
- 6.3.2.2 UK Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.3 Germany
- 6.3.3.1 Key Country Dynamics
- 6.3.3.2 Germany Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.4 France
- 6.3.4.1 Key Country Dynamics
- 6.3.4.2 France Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.5 Italy
- 6.3.5.1 Key Country Dynamics
- 6.3.5.2 Italy Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.6 Spain
- 6.3.6.1 Key Country Dynamics
- 6.3.6.2 Spain Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.7 Denmark
- 6.3.7.1 Key Country Dynamics
- 6.3.7.2 Denmark Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.8 Sweden
- 6.3.8.1 Key Country Dynamics
- 6.3.8.2 Sweden Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.3.9 Norway
- 6.3.9.1 Key Country Dynamics
- 6.3.9.2 Norway Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.4 Asia Pacific
- 6.4.1 Asia Pacific Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.4.2 Japan
- 6.4.2.1 Key Country Dynamics
- 6.4.2.2 Japan Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.4.3 China
- 6.4.3.1 Key Country Dynamics
- 6.4.3.2 China Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.4.4 India
- 6.4.4.1 Key Country Dynamics
- 6.4.4.2 India Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.4.5 Australia
- 6.4.5.1 Key Country Dynamics
- 6.4.5.2 Australia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.4.6 South Korea
- 6.4.6.1 Key Country Dynamics
- 6.4.6.2 South Korea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.4.7 Thailand
- 6.4.7.1 Key Country Dynamics
- 6.4.7.2 Thailand Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.5 Latin America
- 6.5.1 Latin America Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.5.2 Mexico
- 6.5.2.1 Key Country Dynamics
- 6.5.2.2 Mexico Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.5.3 Brazil
- 6.5.3.1 Key Country Dynamics
- 6.5.3.2 Brazil Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.5.4 Argentina
- 6.5.4.1 Key Country Dynamics
- 6.5.4.2 Argentina Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.6 Middle East & Africa (Mea)
- 6.6.1 Mea Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.6.3 South Africa
- 6.6.3.1 Key Country Dynamics
- 6.6.3.2 South Africa Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.6.4 Saudi Arabia
- 6.6.4.1 Key Country Dynamics
- 6.6.4.2 Saudi Arabia Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.6.5 UAE
- 6.6.5.1 Key Country Dynamics
- 6.6.5.2 UAE Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
- 6.6.6 Kuwait
- 6.6.6.1 Key Country Dynamics
- 6.6.6.2 Kuwait Intravenous Solutions Market Estimates And Forecasts, 2018 - 2030 (Revenue In USD Million And Volume In Thousand Units)
Chapter 7 Competitive Analysis
- 7.1 Company Categorization
- 7.1.1 Fresenius Kabi AG
- 7.1.2 Pfizer Inc.
- 7.1.3 Otsuka Pharmaceutical Co. Ltd.
- 7.1.4 Baxter, B. Braun Melsungen AG
- 7.1.5 Vifor Pharma Management Ltd.
- 7.1.6 JW Life Science
- 7.2 Participants' Overview
- 7.3 Financial Performance
- 7.4 Product Benchmarking
- 7.5 Market Participant Categorization
- 7.5.1 Heat Map Analysis
- 7.6 Company Market Share Analysis, 2022
- 7.7 Strategy Mapping
- 7.7.1 Mergers & Acquisitions
- 7.7.2 Product Launch
- 7.7.3 Partnerships & Collaborations
- 7.7.4 Product Approvals
- 7.7.5 Expansion
- 7.7.6 Others
